[{"Assets_0_Q1_USD":208261000.0,"CommonStockSharesOutstanding_0_Q1_shares":98674153.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-13078000.0,"NetIncomeLoss_1_Q1_USD":-17885000.0,"StockholdersEquity_0_Q1_USD":167808000.0,"Ticker":"IBRX","CIK":"1326110","name":"NANTKWEST, INC.","OfficialName":"ImmunityBio Inc. Common Stock","form":"10-Q","period":"20190331","fy":"2019.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1985576569.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Commercial Physical & Biological Resarch","Market":"NASDAQ","SP500":"nan","filed":"20190508"}]